Related Experiment Video

Updated: Jul 4, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

400

A New Strategy for Obesity Treatment: Revealing the Frontiers of Anti-obesity Medications

Pan-Feng Huang1,2, Qi-Yu Wang1,2, Rong-Bin Chen1

  • 1Department of Metabolism and Endocrinology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.

Current Molecular Medicine
|January 30, 2024
PubMed

Insights

Drug repurposing offers a promising strategy to combat the obesity epidemic. Existing medications for conditions like diabetes and cancer show potential anti-obesity effects, improving treatment options.

Area of Science:

  • Pharmacology
  • Metabolic Diseases
  • Drug Discovery

Background:

  • Obesity is a global epidemic linked to severe health issues like type 2 diabetes, cardiovascular disease, and cancer.
  • Current anti-obesity drug development is challenging due to high costs and lengthy processes.
  • Drug repurposing presents an innovative approach to identify new obesity treatments.

Purpose of the Study:

  • To explore the potential of repurposing drugs, initially developed for other diseases, as anti-obesity medications.
  • To review the mechanisms of action for these repurposed drugs in treating obesity.
  • To assess the benefits and challenges of using repurposed drugs for obesity management.

Main Methods:

  • Literature review of existing studies on drug repurposing for obesity.
  • Analysis of molecular pathways and cellular targets shared between obesity and other diseases.
  • Examination of drugs initially developed for diabetes, tumors, depression, alcoholism, erectile dysfunction, and Parkinson's disease for anti-obesity effects.

Main Results:

  • Several drugs for non-obesity related conditions demonstrate potential anti-obesity effects.
  • Shared molecular pathways facilitate the identification of repurposed drugs.
  • Mechanisms of action vary, offering diverse therapeutic strategies.

Conclusions:

  • Drug repurposing is a viable and innovative strategy to address the obesity epidemic.
  • Repurposed medications can broaden pharmacological tools for obesity treatment.
  • Further research into mechanisms and clinical application is warranted for successful implementation.
Keywords:
Obesitydrug repositioningdrug repurposingdrug reusepharmacotherapytype 2 diabetes.

More Related Videos

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.0K
Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet13:09

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet

Published on: July 31, 2021

3.7K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
505
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
204
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
234
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
323
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
44